Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Kidney International|June 8, 2007
Malignancy after kidney transplantation: still a challengeJ-L Bosmans, G A Verpooten
JBR-BTR : Organe De La Societe Royale Belge De Radiologie (SRBR) = Orgaan Van De Koninklijke Belgische Vereniging Voor Radiologie (KBVR)|April 2, 2004
Renovascular hypertension: diagnostic and therapeutic challengesJ L Bosmans, M E De Broe
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 26, 2016
Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies?R Hellemans, J-L Bosmans, D Abramowicz
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 24, 2012
Cost analysis in favor of a combined approach for cytomegalovirus after kidney transplantation: a single-center experienceR Hellemans, P Beutels, M Ieven, et al.
Allergy|January 18, 2006
Haemodialysis-associated anaphylactic and anaphylactoid reactionsD G Ebo, J L Bosmans, M M Couttenye, et al.
Kidney International|August 5, 1998
A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseasesS B Vercauteren, J L Bosmans, M M Elseviers, et al.
Transplantation Proceedings|March 31, 2009
Simultaneous kidney-parathyroid allotransplantation from a single donor after 20 years of tetany: a case reportT Chapelle, K Meuris, G Roeyen, et al.
Clinical Nephrology|August 28, 2003
Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patientsW Engelen, G A Verpooten, M Van der Planken, et al.
Analytical and Quantitative Cytology and Histology|August 31, 2000
Morphometric analysis of renal vessels. Advantage of the multisector area approach to cross-sectionsA T Woestenburg, P P Mensch, J L Bosmans, et al.
Clinical Nephrology|March 30, 2007
Reduced-exposure cyclosporine is safe and efficacious in de novo renal transplant recipients treated with enteric-coated mycophenolic acid and basiliximabK Budde, J L Bosmans, J Sennesael, et al.
Pageof 2